![Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab–carboplatin–paclitaxel and carboplatin–paclitaxel: A retrospective cohort study]()
Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab–carboplatin–paclitaxel and carboplatin–paclitaxel: A retrospective cohort studyLanger, Corey; Ravelo, Arliene; Hazard, Sebastien J.; Guerin, Annie; Ionescu-Ittu, Raluca; Latremouille-Viau, Dominick; Wu, Eric Q.; Ramalingam, Suresh · Lung Cancer · 2014